{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:03:51Z","timestamp":1790345031616,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.lungcan.2026.109516","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:07:30Z","timestamp":1782850050000},"page":"109516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["ULK1, a novel therapeutic target to delay drug tolerance to EGFR\u2013TKIs in an EGFR-mutant non-small cell lung cancer model"],"prefix":"10.1016","volume":"218","author":[{"given":"Ayako","family":"Morita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kammei","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6305-7126","authenticated-orcid":false,"given":"Tadahiro","family":"Kuribayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-936X","authenticated-orcid":false,"given":"Shuta","family":"Tomida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4165-5674","authenticated-orcid":false,"given":"Naofumi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0638-8435","authenticated-orcid":false,"given":"Go","family":"Makimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichiro","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2545-3052","authenticated-orcid":false,"given":"Toshio","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadoaki","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0112-0843","authenticated-orcid":false,"given":"Katsuyuki","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9043-1327","authenticated-orcid":false,"given":"Nobuaki","family":"Ochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2966-106X","authenticated-orcid":false,"given":"Eiki","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lungcan.2026.109516_b0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.lungcan.2026.109516_b0010","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or Chemotherapy for Non\u2013Small-Cell Lung Cancer with Mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.lungcan.2026.109516_b0015","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs","volume":"311","author":"Kris","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109516_b0020","article-title":"Drug-tolerant persister cells in cancer: bridging the gaps between bench and bedside","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109516_b0025","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.jtho.2021.07.017","article-title":"Mechanism of Drug Tolerant Persister Cancer Cells: the Landscape and Clinical Implication for Therapy","volume":"16","author":"Mikubo","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109516_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044126","article-title":"Unraveling the Impact of Intratumoral Heterogeneity on EGFR Tyrosine Kinase Inhibitor Resistance in EGFR-Mutated NSCLC","volume":"24","author":"Kobayashi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109516_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-08074-0","article-title":"AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells","volume":"10","author":"Taniguchi","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109516_b0040","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2020.10.027","article-title":"Persistent Cancer Cells: the Deadly Survivors","volume":"183","author":"Shen","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.lungcan.2026.109516_b0045","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41571-023-00815-5","article-title":"Drug-tolerant persister cells in cancer: the cutting edges and future directions","volume":"20","author":"Pu","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109516_b0050","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1158\/0008-5472.CAN-16-2300","article-title":"SFK\/FAK Signaling Attenuates Osimertinib Efficacy in both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer","volume":"77","author":"Ichihara","year":"2017","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109516_b0055","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","article-title":"The role of autophagy in cancer: therapeutic implications","volume":"10","author":"Yang","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109516_b0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-016-0341-2","article-title":"Resistance to receptor tyrosine kinase inhibitors in solid tumors: can we improve the cancer fighting strategy by blocking autophagy?","volume":"16","author":"Aveic","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.lungcan.2026.109516_b0065","doi-asserted-by":"crossref","unstructured":"Li Y yuan, Lam S kwan, Mak JC wo, Zheng C yan, Ho JCM. Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer. Lung Cancer. 2013;81(3):354-361. doi: 10.1016\/J.LUNGCAN.2013.05.012.","DOI":"10.1016\/j.lungcan.2013.05.012"},{"issue":"10","key":"10.1016\/j.lungcan.2026.109516_b0070","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/JTO.0b013e318262de4a","article-title":"A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer","volume":"7","author":"Goldberg","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109516_b0075","first-page":"414","article-title":"Chloroquine may induce endothelial injury through lysosomal dysfunction and oxidative stress","author":"Greg\u00f3rio","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109516_b0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cell.2020.11.018","article-title":"Colorectal Cancer Cells enter a Diapause-like DTP State to survive Chemotherapy","volume":"184","author":"Rehman","year":"2021","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.lungcan.2026.109516_b0085","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","article-title":"Multiplex digital spatial profiling of proteins and RNA in fixed tissue","volume":"38","author":"Merritt","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109516_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020352","article-title":"A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer","volume":"12","author":"Liu","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"17","key":"10.1016\/j.lungcan.2026.109516_b0095","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gad.287524.116","article-title":"Recent insights into the function of autophagy in cancer","volume":"30","author":"Amaravadi","year":"2016","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109516_b0100","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1158\/1541-7786.MCR-22-0343","article-title":"Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia","volume":"21","author":"Bhattacharya","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109516_b0105","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.96992.3","article-title":"Inhibition of ULK1\/2 and KRASG12C controls tumor growth in preclinical models of lung cancer","volume":"13","author":"Ghazi","year":"2024","journal-title":"Elife"},{"issue":"22","key":"10.1016\/j.lungcan.2026.109516_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13225622","article-title":"Understanding the Role of Autophagy in Cancer Formation and Progression is a Real Opportunity to Treat and Cure Human Cancers","volume":"13","author":"Patergnani","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109516_b0115","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1172\/JCI70454","article-title":"Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma","volume":"124","author":"Ma","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109516_b0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/BJ20101894","article-title":"The serine\/threonine kinase ULK1 is a target of multiple phosphorylation events","volume":"440","author":"Sach","year":"2011","journal-title":"Biochem. J"},{"issue":"7","key":"10.1016\/j.lungcan.2026.109516_b0125","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/auto.7.7.15451","article-title":"Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop","volume":"7","author":"L\u00f6ffler","year":"2011","journal-title":"Autophagy"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226005775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226005775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:28:23Z","timestamp":1790342903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226005775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":25,"alternative-id":["S0169500226005775"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109516","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ULK1, a novel therapeutic target to delay drug tolerance to EGFR\u2013TKIs in an EGFR-mutant non-small cell lung cancer model","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109516"}}